Literature DB >> 29981170

Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment.

Xiaoyang Hou1, Yingkai Tao1, Yanyu Pang1, Xinxin Li1, Guan Jiang1, Yanqun Liu1,2.   

Abstract

Nanoparticle-based phototherapies, such as photothermal therapy (PTT) and photodynamic therapy (PDT), exhibit strong efficacy, minimal invasion and negligible side effects in tumor treatment. These phototherapies have received considerable attention and been extensively studied in recent years. In addition to directly killing tumor cells through heat and reactive oxygen species, PTT and PDT can also induce various antitumor effects. In particular, the resultant massive tumor cell death after PTT and PDT triggers immune responses, including the redistribution and activation of immune effector cells, the expression and secretion of cytokines and the transformation of memory T lymphocytes. The antitumor effects can be enhanced by immune checkpoint blockage therapy. This article reviewed the recent advances of nanoparticle-based PTT and PDT, summarized the studies on nanoparticle-based photothermal and photodynamic immunotherapies in vitro and in vivo, and discussed challenges and future research directions.
© 2018 UICC.

Entities:  

Keywords:  immune checkpoint inhibitor; immunotherapy; nanoparticle; photodynamic therapy; photothermal therapy; tumor

Mesh:

Substances:

Year:  2018        PMID: 29981170     DOI: 10.1002/ijc.31717

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

Review 1.  Photothermal therapies to improve immune checkpoint blockade for cancer.

Authors:  Preethi B Balakrishnan; Elizabeth E Sweeney; Anvitha S Ramanujam; Rohan Fernandes
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

2.  Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.

Authors:  Marisa E Aikins; Cheng Xu; James J Moon
Journal:  Acc Chem Res       Date:  2020-10-05       Impact factor: 22.384

Review 3.  Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.

Authors:  Zachary R Stephen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2020-11-25       Impact factor: 9.933

4.  pH-Responsive Pluronic F127-Lenvatinib-Encapsulated Halogenated Boron-Dipyrromethene Nanoparticles for Combined Photodynamic Therapy and Chemotherapy of Liver Cancer.

Authors:  Jingjing Zong; Hao Peng; Xin Qing; Zhe Fan; Wenjing Xu; Xuanlong Du; Ruihua Shi; Yewei Zhang
Journal:  ACS Omega       Date:  2021-04-30

5.  Biosafety, Nontoxic Nanoparticles for VL-NIR Photothermal Therapy Against Oral Squamous Cell Carcinoma.

Authors:  Jinhuan Chen; Qionghua Li; Fei Wang; Ming Yang; Liang Xie; Xin Zeng
Journal:  ACS Omega       Date:  2021-04-19

Review 6.  Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review).

Authors:  Sanjay Anand; Timothy A Chan; Tayyaba Hasan; Edward V Maytin
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-10

Review 7.  Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view.

Authors:  Xingyue Huang; Yang Lu; Mingxue Guo; Shouying Du; Ning Han
Journal:  Theranostics       Date:  2021-06-04       Impact factor: 11.556

Review 8.  Tumor immunotherapy and multi-mode therapies mediated by medical imaging of nanoprobes.

Authors:  Yang Xuan; Meng Guan; Shubiao Zhang
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556

9.  Synthesis of iridium-based nanocomposite with catalase activity for cancer phototherapy.

Authors:  Hang Wu; Qi Jiang; Keyi Luo; Chunping Zhu; Mengmeng Xie; Shige Wang; Zhewei Fei; Jiulong Zhao
Journal:  J Nanobiotechnology       Date:  2021-07-07       Impact factor: 10.435

Review 10.  Local Destruction of Tumors and Systemic Immune Effects.

Authors:  Karl-Göran Tranberg
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.